Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the U.S. Food and Drug Administration (FDA) extended by...
（ビジネスワイヤ） -- シャンハイ・ヘンリウス・バイオテック（2696.HK）とオルガノン（NYSE：OGN）は、米国食品医薬品局（FDA）がPROLIA/XGEVA（デノスマブ）の治験中のバイオシミラーであるHLX14の生物学的...
Wie Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) mitteilten, hat die US-amerikanische Arzneimittelzulassungsbehörde FDA (Food and Drug Administration) den BLA-Antrag (Biologic...
Third quarter 2024 revenue of $1.582 billion, up 4% as-reported and up 5% at constant currency Third quarter 2024 diluted earnings per share of $1.38 and non-GAAP Adjusted diluted earnings per...
Shanghai Henlius Biotech, Inc. (2696.HK) et Organon (NYSE : OGN) annoncent que l'Administration américaine des produits alimentaires et médicamenteux (FDA) a accepté la demande de licence...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.81 | -5.15923566879 | 15.7 | 15.83 | 14.385 | 2642840 | 14.90413612 | CS |
| 4 | -2.38 | -13.7811233353 | 17.27 | 19.045 | 14.385 | 3198734 | 16.40902562 | CS |
| 12 | -7.75 | -34.2314487633 | 22.64 | 22.67 | 14.385 | 2328459 | 17.88023611 | CS |
| 26 | -6.75 | -31.1922365989 | 21.64 | 23.1 | 14.385 | 1961676 | 19.15838795 | CS |
| 52 | 3.75 | 33.6624775583 | 11.14 | 23.1 | 10.835 | 2511724 | 17.18011428 | CS |
| 156 | -16.71 | -52.8797468354 | 31.6 | 39.475 | 10.835 | 2371908 | 22.2605327 | CS |
| 260 | -19.31 | -56.4619883041 | 34.2 | 39.475 | 10.835 | 2466430 | 23.9548355 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
